NCI Reports Record 2025 Performance; Net Profit Reaches RMB 36.28 Billion, Green Investment Climbs to RMB 75.12 Billion

Bulletin Express
03/27

NCI’s 2025 ESG and Corporate Social Responsibility Report shows the insurer achieved new highs across core financial and sustainability metrics.

• Financial highlights: – Net profit attributable to shareholders rose to RMB 36.28 billion. – Total assets increased to RMB 1.90 trillion, while embedded value reached RMB 287.84 billion. – Primary insurance premium income amounted to RMB 195.87 billion; comprehensive solvency margin ratio stood at 210.47 %. – Investment scale serving the real economy totalled RMB 1.31 trillion, with over RMB 360 billion channelled to national-strategy projects.

• Customer protection: – Claims paid during the year reached RMB 14.70 billion, taking cumulative payouts since inception to RMB 136.80 billion. – Policy-oriented health business lowered insureds’ medical burden by RMB 9.14 billion. – Complaint resolution within 15 days was 99.84 %.

• Green finance progress: – Green investment balance rose 4.85 % year on year to RMB 75.12 billion; green bond holdings stood at RMB 57.73 billion. – The company provided RMB 362.27 billion in risk protection to more than 7,600 green-related enterprises.

• Inclusive initiatives: – Over 20 inclusive insurance products were launched; micro and small enterprises received RMB 2.71 trillion in risk cover. – Public-welfare insurance services reached 348,000 rural residents, supported by RMB 70.92 million in assistance funds.

• Digital and operational efficiency: – Information-technology spending totalled RMB 1.26 billion; online underwriting and electronic policy issuance exceeded 99.9 %. – Per-capita greenhouse-gas emissions (Scope 1 & 2) were 4.14 tCO₂e, and 100 % of newly replaced company vehicles were new-energy models.

The Board approved the report in March 2026, confirming that NCI met or surpassed its strategic targets on financial strength, solvency and ESG development for 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10